---
title: Hormone replacement therapy and aging
videoId: Dyid7vWO0zI
---

From: [[foundmyfitness]] <br/> 

## Introduction to Hormonal Changes with Age
Hormone levels change significantly with age in both men and women <a class="yt-timestamp" data-t="02:27:16">[02:27:16]</a>. In women, the decline of key hormones at menopause is often described as falling off a "cliff" due to its dramatic nature <a class="yt-timestamp" data-t="02:37:58">[02:37:58]</a>. For men, testosterone levels typically peak in their 20s and then experience a slow, steady decline, which is a more gradual process than the sharp drop seen in women <a class="yt-timestamp" data-t="03:20:39">[03:20:39]</a>.

## Female Hormone Replacement Therapy (HRT)

### Menopause and its Effects
Menopause involves the significant decline of three crucial hormones: estrogen, progesterone, and testosterone <a class="yt-timestamp" data-t="02:38:15">[02:38:15]</a>. This decline can be dramatic and lead to various symptoms and long-term health consequences <a class="yt-timestamp" data-t="02:38:26">[02:38:26]</a>.

Symptoms of menopause can include:
*   **Vasomotor symptoms:** Hot flashes and night sweats are commonly observed and can disrupt quality of life <a class="yt-timestamp" data-t="02:39:50">[02:39:50]</a>.
*   **Cognitive effects:** Brain fog <a class="yt-timestamp" data-t="02:40:27">[02:40:27]</a>.
*   **Sleep disturbances:** Often related to hot flashes and night sweats <a class="yt-timestamp" data-t="02:40:30">[02:40:30]</a>.
*   **Sexual changes:** Vaginal atrophy, dryness, and reduced libido <a class="yt-timestamp" data-t="02:40:50">[02:40:50]</a>.
*   **Bone health:** A significant consequence is the accelerated destruction of bone density <a class="yt-timestamp" data-t="02:41:26">[02:41:26]</a>. Unlike men, who experience a gradual decline in bone mineral density, women face a sharp decline after menopause <a class="yt-timestamp" data-t="02:41:48">[02:41:48]</a>. This increases the risk of falls and fractures later in life <a class="yt-timestamp" data-t="02:41:53">[02:41:53]</a>.

### The Women's Health Initiative (WHI) Study
The interpretation of the Women's Health Initiative (WHI) study, published in 2001-2002, led to a "disservice" to women, causing an entire generation to be deprived of necessary hormones <a class="yt-timestamp" data-t="02:42:27">[02:42:27]</a>. The study randomized women with and without a uterus into treatment or placebo groups. Women with a uterus received conjugated equine estrogen and medroxyprogesterone acetate (MPA, a synthetic progestin), while those without a uterus received only conjugated equine estrogen <a class="yt{}}{-timestamp" data-t="02:44:30">[02:44:30]</a>.

*   **Misinterpretation:** The study was halted early due to a reported 0.1% higher risk of breast cancer in the CE plus MPA group, which was sensationalized as a 25% *relative* risk increase <a class="yt-timestamp" data-t="02:46:06">[02:46:06]</a>.
*   **Actual Findings:** There was no difference in breast cancer mortality in the CE plus MPA group, a fact that remains true even with 19-year follow-up data <a class="yt-timestamp" data-t="02:47:31">[02:47:31]</a>. In fact, the group receiving CE alone showed a *lower* incidence and mortality from breast cancer <a class="yt-timestamp" data-t="02:47:58">[02:47:58]</a>.
*   **Key Flaw:** It is widely acknowledged that the synthetic progestin (MPA), not estrogen, was likely the culprit behind the small increase in breast cancer incidence <a class="yt-timestamp" data-t="02:48:28">[02:48:28]</a>. MPA is rarely, if ever, used today <a class="yt-timestamp" data-t="02:48:48">[02:48:48]</a>.
*   **Other Flaws:** The study population was older, with women on average 7 to 10 years past menopause, and was generally an unhealthy population <a class="yt-timestamp" data-t="02:45:54">[02:45:54]</a>.

### Current HRT Approaches and Benefits
Current HRT practices use bioidentical hormones and avoid oral administration when possible.

*   **Hormones Used:**
    *   **Estrogen:** Bioidentical estradiol (E2) or estriol (E3) are used <a class="yt-timestamp" data-t="02:50:50">[02:50:50]</a>. Oral estrogen is generally avoided due to a small, non-zero risk of hypercoagulability (increased blood clotting) <a class="yt-timestamp" data-t="02:52:48">[02:52:48]</a>.
    *   **Progesterone:** Micronized oral progesterone is used for women with a uterus to prevent endometrial hyperplasia <a class="yt-timestamp" data-t="02:49:02">[02:49:02]</a>. A progesterone-coated IUD can also be used for local protection <a class="yt-timestamp" data-t="02:49:09">[02:49:09]</a>.
    *   **Testosterone:** Administered to women to help with sexual function (libido, orgasmic function, arousal) and maintaining muscle mass <a class="yt-timestamp" data-t="03:13:35">[03:13:35]</a>. Doses are much lower than those for men, aiming to restore levels to those seen in their 30s and 40s <a class="yt-timestamp" data-t="03:15:17">[03:15:17]</a>.

*   **Administration Methods:**
    *   **Transdermal Patch:** Preferred for estradiol, providing a steady-state level dose <a class="yt-timestamp" data-t="02:53:10">[02:53:10]</a>.
    *   **Creams/Gels:** Topical application of estradiol and estriol (often combined as "Biest") <a class="yt-timestamp" data-t="02:52:21">[02:52:21]</a>. Vaginal estrogen creams or suppositories can address local sexual symptoms <a class="yt-timestamp" data-t="02:55:05">[02:55:05]</a>.
    *   **Pellets:** Estradiol pellets can be inserted subcutaneously, though less preferred due to difficulty in dose adjustment <a class="yt-timestamp" data-t="02:53:57">[02:53:57]</a>.
    *   **Intranasal spray:** (e.g., Nesto) approved for male use, being studied off-label for female libido <a class="yt-timestamp" data-t="03:19:10">[03:19:10]</a>.

*   **Benefits of Early HRT:**
    *   **Reduced Disease Risk:** Initiating HRT at the time of menopause is believed to reduce a woman's risk of heart disease and likely [[understanding_aging_as_a_disease | dementia]] <a class="yt-timestamp" data-t="03:01:05">[03:01:05]</a>. It is either protective or neutral on cancer risk <a class="yt-timestamp" data-t="03:01:19">[03:01:19]</a>.
    *   **Bone Health:** Estrogen is crucial for bone mineral density (BMD) regulation, mediating the conversion of physical force into bone building <a class="yt-timestamp" data-t="03:02:25">[03:02:25]</a>. HRT preserves bone density and provides a higher baseline even if stopped later <a class="yt-timestamp" data-t="03:03:02">[03:03:02]</a>.
    *   **Symptoms:** Alleviates hot flashes, night sweats, brain fog, and sexual symptoms <a class="yt-timestamp" data-t="02:50:50">[02:50:50]</a>.

### Risks and Considerations for HRT
*   **Late Initiation:** Starting HRT late (e.g., 10 years post-menopause) may be counterproductive for Alzheimer's disease risk and might even increase it <a class="yt-timestamp" data-t="02:59:14">[02:59:14]</a>. Early initiation, especially for APOE4 carriers, appears to be beneficial for AD risk <a class="yt-timestamp" data-t="02:59:26">[02:59:26]</a>.
*   **Bone Density Reversal:** Upon stopping estrogen, bone density will decline again, although from a higher baseline <a class="yt-timestamp" data-t="03:02:20">[03:02:20]</a>.
*   **Cost:** Many advanced HRT options, like PCSK9 inhibitors, are expensive and often not covered by insurance without specific criteria <a class="yt-timestamp" data-t="02:23:02">[02:23:02]</a>.

### Monitoring and Personalization
*   **Monitoring Transition:** For women nearing menopause, monitoring day 5 estradiol and FSH levels indicates proximity to menopause <a class="yt-timestamp" data-t="02:56:31">[02:56:31]</a>. A rising FSH is a key indicator <a class="yt-timestamp" data-t="02:56:54">[02:56:54]</a>.
*   **Symptom-Driven Treatment:** Treatment typically begins when women become symptomatic in perimenopause <a class="yt-timestamp" data-t="02:57:32">[02:57:32]</a>.
*   **Dosage:** In full menopause, the goal is to use enough estrogen to bring FSH down to about 25 mIU/mL, which is lower than pre-menopausal levels but sufficient to manage symptoms and preserve bone density <a class="yt-timestamp" data-t="02:58:05">[02:58:05]</a>.
*   **Individualized Care:** Hormone replacement therapy should be highly personalized, with no "paint by numbers" approach <a class="yt-timestamp" data-t="03:18:18">[03:18:18]</a>. Different women respond differently to dosages and administration methods <a class="yt-timestamp" data-t="03:18:32">[03:18:32]</a>.

## Male Hormone Replacement Therapy (TRT)

### Andropause and its Effects
Testosterone levels in men slowly decline starting in their 20s and 30s <a class="yt-timestamp" data-t="03:20:41">[03:20:41]</a>. "Low T" is defined by a combination of low levels and symptoms <a class="yt-timestamp" data-t="03:21:08">[03:21:08]</a>.

Symptoms and signs that may indicate a need for TRT include:
*   Reduction in libido <a class="yt-timestamp" data-t="03:23:21">[03:23:21]</a>
*   Reduction in energy <a class="yt-timestamp" data-t="03:23:21">[03:23:21]</a>
*   Mood changes <a class="yt-timestamp" data-t="03:23:25">[03:23:25]</a>
*   Insulin resistance <a class="yt-timestamp" data-t="03:23:28">[03:23:28]</a>
*   Difficulty putting on muscle mass <a class="yt-timestamp" data-t="03:23:32">[03:23:32]</a>
*   Difficulty recovering from exercise <a class="yt-timestamp" data-t="03:23:34">[03:23:34]</a>

### TRT Administration and Monitoring
*   **Levels vs. Symptoms:** While hormone levels are measured, the impact of testosterone depends on androgen receptor density and function, which cannot be directly measured <a class="yt-timestamp" data-t="03:21:46">[03:21:46]</a>. Therefore, symptoms combined with plausible biochemical levels guide treatment <a class="yt-timestamp" data-t="03:22:52">[03:22:52]</a>.
*   **Dosing Strategy:** It is recommended to aim for a significant increase in testosterone (e.g., from 8 to 20 ng/dL) to observe if symptoms improve <a class="yt-timestamp" data-t="03:24:48">[03:24:48]</a>. If no improvement is seen, the individual's androgen receptors may already be saturated at lower levels <a class="yt-timestamp" data-t="03:25:20">[03:25:20]</a>.
*   **Injection vs. Gel:** Injections are generally preferred over gels due to more consistent absorption <a class="yt-timestamp" data-t="03:25:52">[03:25:52]</a>. Administering testosterone twice a week (e.g., 40-50mg twice weekly) provides a steadier level than bi-weekly injections <a class="yt-timestamp" data-t="03:26:21">[03:26:21]</a>.

### Risks and Considerations for TRT
*   **Prostate Cancer:** Lower testosterone levels are associated with a higher risk of high-grade prostate cancer <a class="yt-timestamp" data-t="03:27:08">[03:27:08]</a>. TRT does not increase the risk of prostate cancer <a class="yt-timestamp" data-t="03:27:16">[03:27:16]</a>.
*   **Benign Prostatic Hypertrophy (BPH):** TRT can potentially increase the size of the prostate <a class="yt-timestamp" data-t="03:27:23">[03:27:23]</a>.
*   **Side Effects:**
    *   Hair loss (in susceptible individuals due to androgen pathways) <a class="yt-timestamp" data-t="03:27:33">[03:27:33]</a>.
    *   Acne (less frequent at physiological replacement levels) <a class="yt-timestamp" data-t="03:27:42">[03:27:42]</a>.
*   **Cardiovascular Events:** In susceptible, high-risk men, there may be a slight short-term increase in cardiovascular event risk (e.g., heart attack) during the first year of TRT, potentially due to increased blood pressure <a class="yt-timestamp" data-t="03:28:49">[03:28:49]</a>. This risk tends to vanish after 2-3 years <a class="yt-timestamp" data-t="03:29:14">[03:29:14]</a>. It is recommended to have blood pressure well-controlled before initiating TRT <a class="yt-timestamp" data-t="03:29:32">[03:29:32]</a>.

## General Considerations and Personalization

*   **Holistic Approach:** Hormonal interventions should be part of a broader [[impact_of_lifestyle_on_aging | lifestyle]] optimization, including [[impact_of_stress_on_aging | stress]] management, adequate sleep, and regular exercise <a class="yt-timestamp" data-t="03:11:50">[03:11:50]</a>.
*   **Monitoring Blood Pressure:** It is crucial for individuals to monitor their blood pressure regularly at home using an automated cuff <a class="yt-timestamp" data-t="03:31:44">[03:31:44]</a>. The ideal target is 120/80 mmHg or better <a class="yt-timestamp" data-t="03:29:46">[03:29:46]</a>. Accurate measurement involves sitting for 5 minutes quietly before taking three readings <a class="yt-timestamp" data-t="03:36:50">[03:36:50]</a>.
*   **[[vitamin_d_and_its_impact_on_aging | Vitamin D and its impact on aging]]:** While direct evidence for specific outcomes of optimal vitamin D levels (e.g., 80 ng/mL) is lacking from RCTs, avoiding [[vitamin_d_and_its_impact_on_aging | Vitamin D deficiency]] is clearly beneficial for bone health <a class="yt-timestamp" data-t="03:11:20">[03:11:20]</a>. There may be cross-talk between [[vitamin_d_and_its_impact_on_aging | vitamin D]] and estrogen signaling that could offer compensatory benefits <a class="yt-timestamp" data-t="03:05:17">[03:05:17]</a>.